Linksbridge SPC
Since 2008, we've:
Impact has driven our business since Linksbridge was founded in 2008.
From the beginning, we set out to expand the capacity of NGOs, IGOs, and nonprofits to improve human lives. We believed consulting and advisory services could be delivered in a values-centered way, profoundly in alignment with the efforts of international development, global health, and other social impact stakeholders.
In 2012, our home state of Washington introduced the social purpose corporation (SPC) framework for companies prioritizing a positive impact on the world around them. The following year, Linksbridge became the first enterprise in our category to secure SPC designation.
Under Washington law, SPCs must produce an annual report sharing their social purpose objectives, progress toward those objectives, and upcoming plans. We're taking this opportunity to state it clearly:
Linksbridge exists to create positive social impact through our work serving clients and partners in global health, global development, education, humanitarian assistance, social justice, and other related fields.
Our vision of impact has grown through the years. In addition to the work we do, we hope to contribute to a better world through our day-to-day conduct as a business and the way we apportion our profits. From our decision to operate as an employee-owned enterprise to the continuing investment of a share of our proceeds in nonprofit grantees through the Linksbridge Foundation, impact drives everything we do. This report provides an overview of how Linksbridge fulfills its obligations as an SPC.
To you, our partners, we offer thanks for your extraordinary work and for giving us the opportunity to help advance it.
Heather Ferguson
Executive Director
In March 2024, our Market Dynamics team hosted the inaugural Global Health Market Shaping (GHMS) Conference in Barcelona.
Outcomes
Our Technical Assistance team in 2024 advanced its support for country-led switches to fewer-dose vials of measle-containing vaccines (MCVs).
Outcomes
Our Data + Analytics team partnered with researchers at the OxLiv Consortium to design scenarios to evaluate CEPI investments, quantifying the potential impacts of vaccines against Lassa fever and other diseases.
Outcomes
Our Strategic Communications team reached over 2,000 subscribers in 2024. Linksbridge delivered intelligence on pharma industry developments in global health, campaign-based health delivery, and more.
Outcomes
Linksbridge is staffed by employee-owners committed to a better world. As an SPC, our social-impact focus guides not only the projects we accept but the way we run our enterprise each day:
Our team welcomed two new hires in 2024:
Almost as soon as we started preparing this report, the global health ecosystem experienced a disruption of shocking, bewildering, terrible scale.
Rash and chaotic policy changes from the U.S. government cut off nutrition for the starving, health clinics for the sick and vulnerable, and medicine (like antiretrovirals) for vast populations in the poorest regions. The apparent obliteration of the United States' foreign aid commitments represents a stark challenge for the world at large.
In addition to the stunning toll on human lives, the radical retrenchment of the U.S. role in international development and global health—coupled with aid reductions from donors including France, Germany, and the United Kingdom—jeopardizes many of our closest partners. A worldwide ecosystem is at risk.
Charting a way forward through these new circumstances will take time. In the near term, Linksbridge has:
In 2025 we're embarking on a project to increase equitable access to insulin in low- and lower-middle-income countries—an initiative that once again brings together stakeholders from the nonprofit space as well as industry.
The objective is to set up an operating model led by global health partners that can define, prioritize, and implement actions to improve insulin market health. An industry partner has provided catalytic funding for this project, contracting directly with Linksbridge. It's a funding arrangement we've not used before, and we've decided to proceed on this basis because the work aligns closely with our social purpose, we have no active engagements in the insulin space that would pose conflicts, and—importantly—no nonprofit funding structure currently exists as an alternative. Our industry partner has agreed to the guardrails we feel are necessary to prevent conflicts of interest and ensure the initiative serves global health.
As this project moves forward, we're committed to staying transparent with our community. We will continue to provide updates on the successes and challenges of this approach.
In solidarity with you, our partners, we reiterate our commitment to impactful work.